These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10824647)

  • 1. Interferons, serotonin and neurotoxicity.
    Menkes DB; MacDonald JA
    Psychol Med; 2000 Mar; 30(2):259-68. PubMed ID: 10824647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
    Pinto EF; Andrade C
    Curr Neuropharmacol; 2016; 14(7):743-8. PubMed ID: 26733280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of methamphetamine abuse during interferon treatment.
    Lampinen TM; Greatheart MS; Schilder AJ; Kowdley K
    Am J Psychiatry; 2007 Sep; 164(9):1439. PubMed ID: 17728435
    [No Abstract]   [Full Text] [Related]  

  • 5. The phenomenology and treatment of interferon-induced depression.
    Loftis JM; Hauser P
    J Affect Disord; 2004 Oct; 82(2):175-90. PubMed ID: 15488246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-induced depression in hepatitis C: an update.
    Keefe B
    Curr Psychiatry Rep; 2007 Jun; 9(3):255-61. PubMed ID: 17521524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon therapy.
    Williams CN
    Can J Gastroenterol; 1997 Oct; 11(7):563-4. PubMed ID: 9395755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Persecution syndrome after the use of interferon: a case report].
    Lemonnier E; Condat B; Paillère-Martinot ML; Chollet R; Allilaire JF
    Ann Med Psychol (Paris); 1996 Jun; 154(4):246-8; discussion 248-9. PubMed ID: 8929053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced depression: strategies in treatment.
    Asnis GM; De La Garza R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):808-18. PubMed ID: 15907352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon and plasma lipids].
    García-Escaño MD; Andrade RJ; González-Santos P
    Med Clin (Barc); 2000 Jan; 114(2):74-6. PubMed ID: 10702954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurologic side effects of interferon therapy].
    Kohira I
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):610-3. PubMed ID: 10434732
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression from interferon therapy in patients with hepatitis C.
    Miyaoka H; Otsubo T; Kamijima K; Ishii M; Onuki M; Mitamura K
    Am J Psychiatry; 1999 Jul; 156(7):1120. PubMed ID: 10401474
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the Literature.
    Wangensteen KJ; Krawitt EL; Hamill RW; Boyd JT
    Clin Neuropharmacol; 2016; 39(1):1-5. PubMed ID: 26757310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological screening before interferon therapy.
    Scalori A; Apale P; Roffi L
    Hepatology; 2001 Feb; 33(2):480. PubMed ID: 11172355
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential mechanisms of interferon neurotoxicity.
    Bender CM; Monti EJ; Kerr ME
    Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human interferons: biological and clinical promises and premises].
    Jasmin C
    Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferons and autoimmune diseases].
    Niino M; Miyazaki Y
    Brain Nerve; 2013 Nov; 65(11):1381-8. PubMed ID: 24200616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C.
    Matthews SC; Paulus MP; Dimsdale JE
    Psychosomatics; 2004; 45(4):281-6. PubMed ID: 15232040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric complications of interferons: classification, neurochemical bases, and management.
    Malek-Ahmadi P; Hilsabeck RC
    Ann Clin Psychiatry; 2007; 19(2):113-23. PubMed ID: 17612851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.